Rion Therapeutics
Rion is a clinical-stage regenerative medicine company developing novel regenerative technologies to solve unmet medical needs. Rion has established its exosome therapeutic platform, call Purified Exosome Product (“PEP”), as the first-ever fully off-the-shelf regenerative medicine with widespread tissue healing application. Rion is pursuing clinical programs for PEP therapeutic application in wound healing, acute myocardial infarction, Crohn’s fistulizing disease, female stress urinary incontinence, and pulmonary diseases.
